Therefore, we evaluated the circulating biomarkers GDF-15, H-FABP, suPAR, and VCAM-1 in a single center cohort of advanced heart failure patients clinically presenting in the chronic and acute forms, thus aiming to show their sensitivity to HF decompensation [13]. The gene discussed is GDF15; the disease is heart failure.